![Michel Ducreux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michel Ducreux active positions
Companies | Position | Start | End |
---|---|---|---|
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Corporate Officer/Principal | - | - |
Career history of Michel Ducreux
Statistics
International
United States | 2 |
Operational
Corporate Officer/Principal | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
- Stock Market
- Insiders
- Michel Ducreux
- Experience